共 127 条
[1]
Eisenhauer EA(1994)European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high dose versus low dose and long versus short infusion J Clin Oncol 12 2654-2666
[2]
ten Bokkel Huinink WW(1996)Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patient with stage III and IV ovarian cancer N Engl J Med 344 1-6
[3]
Swenerton KD(2002)Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in non-small cell lung cancer: a phase III randomized trial J Clin Oncol 20 3578-3585
[4]
Gianni L(1997)Simplified regimen for the prevention of paclitaxel-associated hypersensitivity reaction J Clin Oncol 15 3517-1902
[5]
Myles J(1996)Carboplatin and paclitaxel in ovarian cancer: a phase I study of Gynecologic Oncology Group J Clin Oncol 14 1895-124
[6]
van der Burg ME(1998)Single-dose dexamethasone paclitaxel premedication Gynecol Oncol 69 122-105
[7]
Kerr I(2000)Paclitaxel-associated hypersensitivity reaction: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center J Clin Oncol 18 102-141
[8]
Vermorken JB(2001)Role of formulation vehicles in taxanepharmacology Invest N drugs 19 125-337
[9]
Buser K(1985)Allergic reaction associatied with cremophor E containing antineoplastic Proc Am Clin Oncol 4 268-735
[10]
Colombo N(2000)Inter-relationships of paclitaxel disposition, infusion duration and cremophor EL kinetics in cancer patients Anti-Cancer Drugs 11 331-1268